Crossmark

Is it possible NET-redifferentiation after chemotherapy? Ga68 DOTA-peptide imaging as a game-changer in therapy management

Crossref DOI link: https://doi.org/10.1016/j.remnie.2018.10.015

Published Print: 2020-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Ergül, Nurhan

Çermik, Tevfik Fikret

Dursun, Nevra
License Information

Text and Data Mining valid from 2020-01-01
More Information

This article is maintained by: Elsevier

Article Title: Is it possible NET-redifferentiation after chemotherapy? Ga68 DOTA-peptide imaging as a game-changer in therapy management

Journal Title: Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.remnie.2018.10.015

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.remn.2018.10.002

Content Type: simple-article

Copyright: © 2018 Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Medicina Nuclear e Imagen Molecular.